Oligometastatic prostate cancer: Metastases-directed therapy? - Wikidata - wikimedia - TriplyDB

Oligometastatic prostate cancer: Metastases-directed therapy?

Oligometastatic prostate cancer: Metastases-directed therapy?

http://www.wikidata.org/entity/Q26740069

about

Artesunate suppresses the viability and mobility of prostate cancer cells through UCA1, the sponge of miR-184 Evaluation of tumor recurrences after radical prostatectomy using 18F-Choline PET/CT and 3T multiparametric MRI without endorectal coil: a single center experience.

P2860

Q33566906-80F583D0-12DE-4B49-AEA2-5A1D72F76BD3 Q39123279-2466D774-83A0-4A46-B77B-010ECFB846E0

P2860

Oligometastatic prostate cancer: Metastases-directed therapy?

http://www.wikidata.org/entity/Q26740069

description

2016 nî lūn-bûn

@nan

2016 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

name

Oligometastatic prostate cancer: Metastases-directed therapy?

@ast

Oligometastatic prostate cancer: Metastases-directed therapy?

@en

Oligometastatic prostate cancer: Metastases-directed therapy?

@nl

type

label

Oligometastatic prostate cancer: Metastases-directed therapy?

@ast

Oligometastatic prostate cancer: Metastases-directed therapy?

@en

Oligometastatic prostate cancer: Metastases-directed therapy?

@nl

prefLabel

Oligometastatic prostate cancer: Metastases-directed therapy?

@ast

Oligometastatic prostate cancer: Metastases-directed therapy?

@en

Oligometastatic prostate cancer: Metastases-directed therapy?

@nl

P1433

Q26740069-49802275-C6BA-4050-BC4C-78F786A82FA5

P1476

Q26740069-B95D0C62-4939-405B-85B5-FE416C0A1BD6

P2093

Q26740069-1D3F10CB-E73C-4FCE-B084-90DF335A104D

Q26740069-EA791069-DCA7-4F2A-BB84-402736A2E5EE

P2860

Q26740069-03574F01-4FED-42B1-9066-AF3D1F5608B5

Q26740069-17B23536-C04A-4BC0-9D27-8AF40A11275E

Q26740069-2343A219-F35C-4824-AE24-3849303DF4ED

Q26740069-325C1062-14BF-46A6-9896-4DFEF2A2A4DF

Q26740069-345992F0-0A61-4763-BCF1-DD8C0113719F

Q26740069-43AF542F-2F3F-44B5-BB6B-3741AF7E623C

Q26740069-45D76C34-0546-4BD4-BE22-999A1C27B042

Q26740069-48947EDF-0377-4BEF-90B5-DCD271A255C6

Q26740069-55E8170F-8323-4227-AD2A-BA630293A1E8

Q26740069-609E1D6F-97D2-40AC-BA24-DC84F2A2D6C8

P304

Q26740069-7E66CAE9-EDB0-4A46-826E-176EF5A031B7

P31

Q26740069-DA22E03B-D4A9-40C0-9D3D-BB4D9B43BF1A

P3181

Q26740069-42CF4CAE-8ABD-4A54-82A3-57C17421133C

P356

Q26740069-A1F84C0C-4D8C-4A94-A701-138DB22027B2

P407

Q26740069-616414EC-F980-47BE-8395-18116E2D918D

P433

Q26740069-2F26EFD6-5E1D-4BFF-9604-86C6DD6EE22A

P478

Q26740069-6A53866F-5823-46F2-832D-9E7E15A3551B

P50

Q26740069-09791BB5-EC5E-467C-BE3F-15E2EC6C815C

P577

Q26740069-E69FBF7C-7B9E-4194-9D87-27CAA7D106F4

P698

Q26740069-59B16F68-A961-426F-AD44-25035E1E67D6

P932

Q26740069-AFD79DD2-B136-4DB2-9515-EF67C2348672

P3181

P356

J.AJU.2016.06.004

P1433

Arab Journal of Urology Arab Association of Urology

P1476

Oligometastatic prostate cancer: Metastases-directed therapy?

@en

P2093

Gert De Meerleer

http://www.w3.org/2001/XMLSchema#string

Hein Van Poppel

http://www.w3.org/2001/XMLSchema#string

P2860

Oligo- and polymetastatic progression in lung metastasis(es) patients is associated with specific microRNAs

Repeated stereotactic body radiotherapy for oligometastatic prostate cancer recurrence

[11C]Choline PET/CT for targeted salvage lymph node dissection in patients with biochemical recurrence after primary curative therapy for prostate cancer. Preliminary results of a prospective study.

Stereotactic body radiation therapy in the treatment of oligometastatic prostate cancer.

Extracranial oligometastases: a subset of metastases curable with stereotactic radiotherapy.

Metastasis-directed therapy of regional and distant recurrences after curative treatment of prostate cancer: a systematic review of the literature.

Radiotherapy for oligometastases and oligo-recurrence of bone in prostate cancer.

Extended salvage pelvic lymph node dissection in patients with recurrent prostate cancer.

Is there a favorable subset of patients with prostate cancer who develop oligometastases?

Safety and feasibility of image-guided robotic radiosurgery for patients with limited bone metastases of prostate cancer.

P304

179-182

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4470118

http://www.w3.org/2001/XMLSchema#string

P356

10.1016/J.AJU.2016.06.004

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-07-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27547457

http://www.w3.org/2001/XMLSchema#string

P932

4983156

http://www.w3.org/2001/XMLSchema#string